Chronos Archive seal

Review checklist: Josephine Baker (HR-ML049)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the attribution of breathlessness to ticagrelor and the switch to clopidogrel with a 600 mg load, twelve months of dual antiplatelet therapy, metoprolol with an ejection fraction of 52%, lisinopril for blood pressure, the missed potassium check, the nosebleed managed without stopping antiplatelets, the exercise test before a return to the stage, the hysterectomy counted as a possible early menopause, and PHQ-9 scores below 10 without a safety assessment.
provenance reviewnot_startedSources: the French Ministry of the Armed Forces, the National Park Service, a La Croix dossier hosted by the Château des Milandes, Women in World History, the Women's History Network, the INA archive, Biography.com, a Library of Congress guide and the National Women's History Museum. The Panthéon (Centre des monuments nationaux) site, the Smithsonian NMAAHC page and the New York Times obituary could not be fetched; Jean-Claude Baker's and Bennetta Jules-Rosette's books were not read. A heart attack in 1964 could not be verified and is not used.
safe messaging reviewnot_startedPoverty, racism, the pregnancy loss and the eviction are recorded plainly as history, without graphic detail. The claim about the pregnancy loss and hysterectomy is marked sensitive. Mood screening is synthetic and below the threshold for a safety assessment. Her adopted children are not named, and no relative or other real person is given a modern statement, decision or health fact.

Judgment calls (dossier editorial resolutions)

  1. Sources. The case relies on the French Ministry of the Armed Forces, the National Park Service, a La Croix dossier reproduced by the Château des Milandes, Women in World History, the Women's History Network, the INA archive, Biography.com, a Library of Congress research guide and the National Women's History Museum. The Panthéon and Centre des monuments nationaux pages, the Smithsonian NMAAHC page (refused the request) and the New York Times obituary could not be fetched. Jean-Claude Baker's biography and Bennetta Jules-Rosette's work were not read and are not cited. Wikipedia and popular sites found in searches were not used. The National Park Service page is hosted by a historic site named for another figure in the dataset; the publisher is given as the National Park Service only, so that name does not appear.
  2. Recent-death rule. She died in 1975, so the rule does not apply. A sick visit is included.
  3. Index age and dates (correction to the brief). The brief proposed an index at 57 to 58 in 1964, after a heart attack often said to have happened that year. No reliable source read dates a heart attack to 1964; the claim appears only on low-quality sites. La Croix records a heart attack on the day of her eviction from Les Milandes in March 1969, called a new one, with a hospital admission in Périgueux. The index visit is therefore April 14, 2026, which maps to April 14, 1969, when she was 62, three weeks after the modern heart attack placed on March 24 (mapping to March 1969). The synthetic date of birth is 1963-06-03, a shift of 57 years. The visits on April 28, May 26, June 16, July 21, September 15 and October 20, 2026 map to the same days of 1969. Where she was day to day in 1969 is not documented in the sources read; nothing places a visit in conflict with a documented event. The presenting pattern chosen is the early post-infarction follow-up visit with breathlessness on exertion.
  4. Morocco illness. The long stay in hospital in Casablanca from June 1941 to December 1942, with five operations, is D (La Croix, with Women in World History agreeing that she was critically ill and had several operations). The pregnancy loss is disputed (stillbirth in Women in World History, miscarriage in the Women's History Network), and the hysterectomy, peritonitis and septicemia rest on the Women's History Network alone, so that claim (CLM-0008) is R, certainty “possible,” and marked sensitive. Whether her ovaries were removed is not recorded in any source read.
  5. Surgical menopause (correction to the brief). The brief called the hysterectomy a documented surgical menopause. A hysterectomy alone does not cause menopause unless the ovaries are removed or lose their blood supply, and the sources do not say. The record lists the absence of the uterus (Z90.710, verification provisional, linked to CLM-0008) and treats a possible early menopause as a risk-enhancing factor for heart disease and osteoporosis, citing the AHA statement on the menopause transition. Hormone therapy is not used for prevention.
  6. Name and alias. The display name splits simply into given and family names, so identity.name_parts is not used. The alias Freda Josephine McDonald (National Park Service, Biography.com, National Women's History Museum) appears in no other record. The notes call her Ms. Baker.
  7. Living people and relatives. Her twelve adopted children are documented history only and are never named, because some are living; in the modern social history they appear only as her family, without any role, statement or health fact. Jo Bouillon appears only in a claim. The friend named as her health care agent and the social worker are synthetic and unnamed. No relative or historical person is given a modern statement, decision or health fact. The record never names the speaker who followed her at the March on Washington.
  8. Conflicts recorded. French citizenship in 1937 (Ministry of the Armed Forces, La Croix) against 1936 (National Park Service); twelve adopted children against 13 (National Women's History Museum); death on April 12, 1975 against April 14 (Women in World History). The Panthéon cenotaph is recorded; her burial in Monaco is from La Croix.
  9. Coronary disease and the 1969 heart attack. The modern non-ST-elevation myocardial infarction with a stent to the right coronary artery is synthetic and is linked to the documented 1969 heart attack (placement both_with_link). The later heart attacks, cerebral emboli and the stroke of 1973 are recorded as later history only. Her death from a cerebral hemorrhage is recorded as a stroke from bleeding in the brain, not a heart attack.
  10. Presenting problem and diagnosis. Breathlessness on exertion with tiredness (R06.09) is the presenting problem, resolved at the second visit when the echocardiogram (ejection fraction 52%, normal filling pressures), normal oxygen saturation, normal hemoglobin and the history of air hunger at rest beginning days after ticagrelor led to the diagnosis of ticagrelor-related breathlessness (T45.525A), recorded at the second visit and resolved at the third after the change to clopidogrel. Raised lipoprotein(a) (E78.41) is recorded at the second visit, when it was measured. The intake documents show only what was known at intake.
  11. Treatment choices. (1) Ticagrelor was changed to clopidogrel with a 600 mg loading dose 24 hours after the last ticagrelor dose, without a gap, rather than stopped; clopidogrel is less potent, and the change is a judgment the owner may review. (2) Twelve months of dual antiplatelet therapy, ending after the episode; the goal is recorded as active. (3) Atorvastatin 80 mg; LDL 146 to 62 mg/dL; ezetimibe was not needed. (4) Metoprolol succinate 25 mg with an ejection fraction of 52%, continued beyond the first year because of high blood pressure. (5) Lisinopril for high blood pressure, raised to 10 mg. (6) A nosebleed on dual antiplatelet therapy was managed without stopping either drug. (7) A symptom-limited exercise test before full performances, to prescribe exercise, not as surveillance.
  12. Depression screening. The PHQ-2 (2) and PHQ-9 (7, item 9 scored 0) at intake, and the PHQ-9 at twelve weeks (3), are synthetic and below the thresholds that require a safety assessment, so none is included and no F-code is used. The mild symptoms are attributed to the heart attack and the loss of her home in the modern episode; nothing is claimed about her real mood.
  13. Equity. The teaching on underdiagnosis and undertreatment of heart disease in women and Black women cites the AHA statement on myocardial infarction in women and a Get With The Guidelines analysis published in an AHA journal; the record does not quote figures from them beyond what the abstracts state. Her delayed arrival at hospital and her request to be taken seriously (SOC-007) are synthetic statements in the modern episode, written to guide respectful care.
  14. Social history. Her debts, the 1964 appeal and the loss of Les Milandes anchor the financial strain (Z59.86). Her career, Resistance service and civil rights work anchor her occupation and strengths. Tobacco and alcohol use are not documented in the sources read; the modern history records her as a never smoker who rarely drinks, as a synthetic choice. Her insurance is not specified.
  15. Synthetic clinical picture. Everything in the modern episode is synthetic: symptoms, the hospital course and angiogram, every blood pressure, all laboratory values, the ECG, the echocardiogram, the exercise test, scores (PHQ-2, PHQ-9, Seattle Angina Questionnaire-7, AUDIT-C), the screening results at the seven-month visit (FIT, mammogram, hepatitis C, HIV, DXA and optometry, all narrative), medicines and outcomes. Height (168 cm) and weights are synthetic. Reference ranges are typical adult female ranges; the LDL range uses the secondary-prevention goal.
  16. Sick visit. An anterior nosebleed (R04.0) on aspirin and clopidogrel in dry weather, chosen because it follows from dual antiplatelet therapy and insinuates no undocumented diagnosis; hemoglobin 11.9 g/dL; managed with first aid, saline and petroleum jelly, with antiplatelets continued. It is not a historical claim.
  17. Preventive visit. A periodic adult preventive visit at 63 (CPT 99396 and 99497 in plain text). Judgment calls: FIT instead of colonoscopy during the first year of dual antiplatelet therapy; no cervical screening after a hysterectomy for a reason other than cancer; DXA before 65 because of a possible early menopause; influenza, COVID-19 and PCV20 that day, with RSV (heart disease, age 50 to 74), zoster and Tdap at the next visit; advance care planning with an unnamed friend as agent.
  18. Focused visits. The four chronic-care follow-ups (two weeks with the consultation, four weeks after the change to clopidogrel, the twelve-week review after rehabilitation, and seven months) are documented as focused visits on the CMID ischemic heart disease and acute myocardial infarction monographs, the 2023 chronic coronary disease guideline and the 2025 acute coronary syndromes guideline. Two deviations are recorded instead of invented results: (1) the metabolic panel due one to two weeks after lisinopril was raised was missed because the order went to the clinic laboratory and she had no ride; it was drawn four weeks after the change (potassium 4.7 mmol/L, creatinine 0.88 mg/dL), so no harm resulted; (2) the lipid panel due four to eight weeks after the statin start was missed with the same trip and not added at the third visit by oversight; the first panel after it, at the twelve-week review, showed LDL 62 mg/dL at goal, so no change in treatment was delayed. The corrective action for both was laboratory tests drawn at the rehabilitation center on session days. Synthetic findings introduced: ticagrelor-related breathlessness, lipoprotein(a) 172 nmol/L, the nosebleed, the exercise test and the screening results.
  19. Consultation. The cardiology referral and the consultation by Laurent Mbeki-Fontaine, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: ticagrelor-related breathlessness with deconditioning, not heart failure or ischemia; an ejection fraction of 52% with no further testing; a change to clopidogrel with a loading dose and twelve months of dual antiplatelet therapy; metoprolol, lisinopril raised to 10 mg, a target below 130/80 and an LDL goal below 70 mg/dL with ezetimibe if not reached; rehabilitation, then an exercise test at about twelve weeks before full performances; and the hysterectomy and possible early menopause as risk-enhancing factors, with complete secondary prevention and depression screening.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-26
Progress note 03 (C-CDA)
Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitorOne to two weeks after a start or dose change, then every six to twelve monthsThe panel due one to two weeks after lisinopril was raised to 10 mg was missed: the order went to the clinic laboratory and she had no ride on its opening days. It was drawn today, four weeks after the change: potassium 4.7 mmol/L and creatinine 0.88 mg/dL (eGFR 74), so no harm resulted. Corrective action: laboratory tests drawn at the rehabilitation center on session days
2026-05-26
Progress note 03 (C-CDA)
Lipid panelFour to eight weeks after a statin start or change, then every three to twelve monthsThe panel due four to eight weeks after the statin start was missed with the same laboratory trip and, by oversight, was not added to today's blood test. Corrective action: added to the standing order at the rehabilitation center and to the twelve-week review; harm is judged on that result

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-04-28
Progress note 02 (C-CDA)
LaboratoryLipid panelOrderedLDL 84 mg/dL at intake, only three weeks after atorvastatin 80 mg was started; panel ordered with the potassium check in one to two weeks
2026-04-28
Progress note 02 (C-CDA)
LaboratoryMetabolic panel (potassium, creatinine, eGFR) on an ACE inhibitorOrderedPotassium 4.4, creatinine 0.82 mg/dL at intake; lisinopril raised today, panel due in one to two weeks
2026-09-15
Progress note 06 (C-CDA)
PreventionBreast cancer screening (mammogram)OrderedEvery two years from 40 to 74; none in many years
2026-09-15
Progress note 06 (C-CDA)
PreventionColorectal cancer screeningOrderedAge 45 to 75; never screened. A stool immunochemical (FIT) kit today, because a colonoscopy within the first year after a stent would mean stopping clopidogrel
2026-09-15
Progress note 06 (C-CDA)
PreventionBone density (DXA)OrderedUnder 65, but at increased risk from a possible early menopause after hysterectomy in her thirties
2026-09-15
Progress note 06 (C-CDA)
PreventionHepatitis C screeningOrderedOne-time screening for adults 18 to 79; never tested
2026-09-15
Progress note 06 (C-CDA)
PreventionHIV screeningOrderedOne-time screening for adults 15 to 65; never tested; she agreed
2026-09-15
Progress note 06 (C-CDA)
PreventionEye examinationReferredOptometry for a routine eye examination; none in several years

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0008The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children.possible

Sensitive claims

ClaimGradeStatement
CLM-0008RThe illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children.

Diagnoses not confirmed

ProblemCodeVerificationReason
Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular riskZ90.710provisionalSynthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-04-14LDL cholesterol84 mg/dL (high)High
2026-04-28Lipoprotein(a)172 nmol/L (high)High